JP2018531905A5 - - Google Patents

Download PDF

Info

Publication number
JP2018531905A5
JP2018531905A5 JP2018511451A JP2018511451A JP2018531905A5 JP 2018531905 A5 JP2018531905 A5 JP 2018531905A5 JP 2018511451 A JP2018511451 A JP 2018511451A JP 2018511451 A JP2018511451 A JP 2018511451A JP 2018531905 A5 JP2018531905 A5 JP 2018531905A5
Authority
JP
Japan
Prior art keywords
thymosin
composition containing
container
containing thymosin
inert gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511451A
Other languages
English (en)
Japanese (ja)
Other versions
JP6996713B2 (ja
JP2018531905A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2015/013981 external-priority patent/WO2017061663A1/ko
Publication of JP2018531905A publication Critical patent/JP2018531905A/ja
Publication of JP2018531905A5 publication Critical patent/JP2018531905A5/ja
Application granted granted Critical
Publication of JP6996713B2 publication Critical patent/JP6996713B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511451A 2015-10-06 2015-12-18 チモシンベータ4を含む眼科用製剤の製造方法 Active JP6996713B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20150140489 2015-10-06
KR10-2015-0140489 2015-10-06
PCT/KR2015/013981 WO2017061663A1 (ko) 2015-10-06 2015-12-18 티모신 베타 4를 포함하는 안약의 제조방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020109496A Division JP2020183391A (ja) 2015-10-06 2020-06-25 チモシンベータ4を含む眼科用製剤の製造方法

Publications (3)

Publication Number Publication Date
JP2018531905A JP2018531905A (ja) 2018-11-01
JP2018531905A5 true JP2018531905A5 (enExample) 2021-10-21
JP6996713B2 JP6996713B2 (ja) 2022-02-04

Family

ID=58487995

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018511451A Active JP6996713B2 (ja) 2015-10-06 2015-12-18 チモシンベータ4を含む眼科用製剤の製造方法
JP2020109496A Pending JP2020183391A (ja) 2015-10-06 2020-06-25 チモシンベータ4を含む眼科用製剤の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020109496A Pending JP2020183391A (ja) 2015-10-06 2020-06-25 チモシンベータ4を含む眼科用製剤の製造方法

Country Status (6)

Country Link
US (1) US10744088B2 (enExample)
EP (1) EP3342398A4 (enExample)
JP (2) JP6996713B2 (enExample)
KR (1) KR102487614B1 (enExample)
HK (1) HK1256595A1 (enExample)
WO (1) WO2017061663A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
CA3114204A1 (en) * 2018-10-10 2020-04-16 Presbyopia Therapies, Inc. Compositions and methods for the treatment of presbyopia
CN112107678B (zh) * 2020-09-30 2022-11-18 辰欣药业股份有限公司 一种含有胸腺法新的冻干组合物及其制备方法
US12180206B2 (en) 2021-11-17 2024-12-31 Lenz Therapeutics Operations, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150744A (en) * 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
KR19980703582A (ko) * 1995-04-04 1998-11-05 가와구치 시게키 염산 프로카테롤 수용액 제제를 보지하는 패키지 및 염산 프로카테롤 수용액 제제
CA2338928A1 (en) 1998-07-30 2000-02-10 Hynda K. Kleinman Thymosin .beta.4 promotes wound repair
MXPA01003729A (es) * 1998-10-14 2002-05-06 Kyowa Hakko Kogyo Kk Metodo para estabilizar una solucion acuosa de derivados de pirazoloacridona.
MX2007001181A (es) * 2004-07-30 2007-03-21 Otsuka Pharma Co Ltd Botella comprimible y envase con gotero oftalmico que usa el mismo.
CN1748704B (zh) * 2004-09-15 2011-05-04 尼普洛株式会社 注射用水溶液制剂及其稳定化方法
CA2612522A1 (en) * 2005-06-17 2006-12-28 Regenerx Biopharmaceuticals, Inc. Lkktet and/or lkktnt peptide compositions and methods
ES2288118B1 (es) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
WO2008108927A2 (en) * 2007-03-06 2008-09-12 Regenerx Biopharmaceuticals, Inc. Methods and compositions for stabilizing polypeptides
MX2009010977A (es) 2007-04-11 2010-02-12 Biomarin Pharm Inc Metodos de administracion de tetrahidrobiopterina, composiciones asociadas y metodos de medicion.
JP5990880B2 (ja) * 2011-08-31 2016-09-14 東レ株式会社 有用タンパク質組成物およびその製造方法

Similar Documents

Publication Publication Date Title
JP2018531905A5 (enExample)
CN103476397B (zh) 一种制备用于注射的含培美曲塞或其盐的无抗氧化剂溶液形式的药物制剂的方法
JP2018502910A5 (enExample)
JP2014518844A5 (enExample)
RS57044B1 (sr) Postupak za proizvodnju stabilnog, injektabilnog rastvora noradrenalina niske koncentracije
CN105472996A (zh) 氢负离子内含物的制备方法及利用其来制备的氢负离子内含物
JP6505114B2 (ja) 抗酸化剤を含有しない薬学組成物およびその製造方法
TW201726611A (zh) 抑制二甲亞碸之分解的方法
CN105616343A (zh) 一种硫辛酸注射液及其制备方法
CN108338988A (zh) 碳酸氢钠林格注射液及制备方法
JP6873923B2 (ja) 安定化された薬学組成物およびその製造方法
CN103068397B (zh) 医用溶液用浓缩物、其制造以及其在透析中的应用
CN105919931B (zh) 一种稳定的盐酸法舒地尔注射液及其制备方法
CN103848763B (zh) 采用有机羧酸或有机羧酸盐添加剂改变牛磺酸晶体形态的方法
KR20160002572A (ko) 고순도 수산화 리튬 수용액의 제조 방법 및 이를 이용한 염수로부터 탄산 리튬의 효율적 추출 방법
AU2015317229B2 (en) Dialysis solution
RU2015100257A (ru) Композиции, содержащие халькогениды, и связанные способы
CN101180051B (zh) 多利培南水溶液的制备方法
JPS62194861A (ja) 液状医薬品包装体
CN109264746A (zh) 一种药用级碳酸氢钠的制备方法
JP7519108B2 (ja) 医薬組成物及びその製造方法
CN103936825B (zh) 邻苯二甲酰-l-丙氨酰-l-谷氨酰胺的绿色制备方法
NO327263B1 (no) Parenterale formuleringer som inneholder 10-hydroksy-10,11-tetrahydrokarbamazepin, enhetsdoseringsform og beholder inneholdende nevnte parenterale formulering, samt anvendelse av nevnte parenterale formulering.
CN107049939A (zh) 一种离子vc口服液及其制备方法
JP2010047482A (ja) エダラボン注射液